About Isaac Manke
Isaac Manke is a director at Addex Therapeutics.
Form D filings name Isaac Manke as a director at OnKure.
Isaac Manke reports to the SEC as a director of 5 public companies, including Rainier Acquisition (RNAQ), OnKure Therapeutics (OKUR) and Q32 Bio (QTTB).
Isaac Manke first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Isaac Manke in the role, so the role may have started earlier or lasted longer.
AL
Addex Therapeutics Ltd.
Director
2026 · Public company (ADXN)
RC
Rainier Acquisition Corp
Director
2026 · Public company (RNAQ)
OI
OnKure Therapeutics, Inc.
Director
2024 – 2026 · Public company (OKUR)
QI
Q32 Bio Inc.
Director
2024 – 2026 · Public company (QTTB)
RI
Renovacor, Inc.
Director
2020 · Public company (RCOR)
Key Colleagues at Startups
The people Isaac Manke works with at each company, as listed on that company's latest Form D.
OnKure, Inc. · Form D, Apr 3, 2023
AP
Anthony Piscopio
Executive officer and director
RC
R. Carruthers
Director
AP
Andrew Phillips
Director
NS
Nicholas Saccomano
Director
DW
Duncan Walker
Executive officer
JW
James Winkler
Executive officer
JL
Jason Leverone
Executive officer
KO
Keith Olivia
Secretary